PDL BioPharma (PDLI)

2.54 -0.02 (0.78%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/1/18 *Est.)

Latest Headlines

Form 8-K PDL BIOPHARMA, INC. For: Oct 09 October 9, 2018 8:37 AM - SEC Filing PDL BioPharma Names Edward Imbrogno Vice President of Finance October 8, 2018 9:00 AM - PR NewsWire Form 8-K PDL BIOPHARMA, INC. For: Oct 02 October 2, 2018 9:25 AM - SEC Filing Form 4 PDL BIOPHARMA, INC. For: Sep 25 Filed by: Monnet Dominique September 27, 2018 4:46 PM - SEC Filing Form 4 PDL BIOPHARMA, INC. For: Sep 25 Filed by: Stone Christopher Lewis September 27, 2018 4:44 PM - SEC Filing Form 4 PDL BIOPHARMA, INC. For: Sep 25 Filed by: GARCIA PETER S September 27, 2018 4:44 PM - SEC Filing Form 4 PDL BIOPHARMA, INC. For: Sep 25 Filed by: Jene Jill M. September 27, 2018 4:43 PM - SEC Filing PDL BioPharma to Present at the 2018 Cantor Fitzgerald Global Healthcare Conference September 26, 2018 9:00 AM - PR NewsWire Form 8-K PDL BIOPHARMA, INC. For: Sep 24 September 24, 2018 9:13 AM - SEC Filing PDL BioPharma (PDLI) Reports New $100M Share Buyback September 24, 2018 9:07 AM - StreetInsider PDL BioPharma Announces New $100 Million Stock Repurchase Program September 24, 2018 9:00 AM - PR NewsWire UPDATE: SevenSaoi Capital LLC Provides Letter to PDL BioPharma (PDLI) Board Highlighting 'Serious Concerns with Company's Failed Acquisition Strategy' September 20, 2018 8:37 AM - StreetInsider SevenSaoi Capital Delivers Letter to the Board of PDL BioPharma September 20, 2018 8:30 AM - PR NewsWire Form 8-K PDL BIOPHARMA, INC. For: Sep 05 September 5, 2018 6:09 AM - SEC Filing PDL BioPharma to Present at the H.C. Wainwright 20th Annual Global Investment Conference August 30, 2018 8:00 AM - PR NewsWire Form 10-Q PDL BIOPHARMA, INC. For: Jun 30 August 9, 2018 4:36 PM - SEC Filing PDL BioPharma (PDLI) Reports Q2 Revenues Above Consensus August 8, 2018 4:39 PM - StreetInsider Form 8-K PDL BIOPHARMA, INC. For: Aug 08 August 8, 2018 4:13 PM - SEC Filing PDL BioPharma Reports Second Quarter 2018 Financial Results August 8, 2018 4:05 PM - PR NewsWire PDL BioPharma (PDLI) Agrees to Purchase Remaining 50% Stake in Royalties & Milestones on Type 2 Diabetes Products from Depomed for Max $20M August 2, 2018 5:28 PM - StreetInsider Form 8-K PDL BIOPHARMA, INC. For: Aug 02 August 2, 2018 4:09 PM - SEC Filing PDL BioPharma Acquires Depomed's Remaining 50% Interest in Royalties and Milestones on Type 2 Diabetes Products August 2, 2018 4:02 PM - PR NewsWire PDL BioPharma to Announce Second Quarter Financial Results on August 8, 2018 August 1, 2018 9:01 AM - PR NewsWire Full Article List